PROFUND VP BIOTECHNOLOGY is a registered fund series of ProFunds (series S000003965). Net assets $41.7M as of 2026-03-31. Index fund.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| AGPXX | — | $999K | 239.26% |
| AGPXX | — | $999K | 239.26% |
| AGPXX | — | $999K | 239.26% |
| AGPXX | — | $999K | 239.26% |
| AGPXX | — | $999K | 239.26% |
| AGPXX | — | $999K | 239.26% |
| AGPXX | — | $999K | 239.26% |
| AGPXX | — | $999K | 239.26% |
| Apellis Pharmaceuticals Inc | — | $746K | 178.77% |
| Apellis Pharmaceuticals Inc | — | $746K | 178.77% |
| Apellis Pharmaceuticals Inc | — | $746K | 178.77% |
| Apellis Pharmaceuticals Inc | — | $746K | 178.77% |
| Apellis Pharmaceuticals Inc | — | $746K | 178.77% |
| Apellis Pharmaceuticals Inc | — | $746K | 178.77% |
| Apellis Pharmaceuticals Inc | — | $746K | 178.77% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $41.7M |
| 2025-12-31 | $41.2M |
| 2025-09-30 | $33.9M |
| 2025-06-30 | $29.1M |
| 2025-03-31 | $29.8M |
| 2024-12-31 | $36.1M |
| 2024-09-30 | $42.3M |
| 2024-06-30 | $42.2M |